Tectonic Therapeutic (TECX) Depreciation & Amortization (CF) (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Depreciation & Amortization (CF) of $304000.0 for Q1 2026, down 15.56% year-over-year from $360000.0 in Q1 2025, and down 8.71% quarter-over-quarter from $333000.0 in Q4 2025.
Tectonic Therapeutic (TECX) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Depreciation & Amortization (CF) for 10 consecutive years, with $304000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 15.56% year-over-year to $304000.0; the TTM figure through Mar 2026 stood at $1.3 million (down 18.98% YoY), while the FY2025 annual figure was $1.4 million, down 16.41% from the prior year.
- Depreciation & Amortization (CF) slipped to $304000.0 in Q1 2026 per TECX's latest filing, from $333000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $508000.0 in Q4 2024 and bottomed at $289000.0 in Q2 2023.
- Historically, Depreciation & Amortization (CF) has averaged $359352.9 across 5 years, with a median of $342000.0 in 2025.
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) jumped 37.11% — and 2025, when it slumped 34.45%.
- Tectonic Therapeutic's Depreciation & Amortization (CF) stood at $335000.0 in 2022, then gained by 11.34% to $373000.0 in 2023, then soared by 36.19% to $508000.0 in 2024, then slumped by 34.45% to $333000.0 in 2025, then fell by 8.71% to $304000.0 in 2026.
- Business Quant data shows TECX's Depreciation & Amortization (CF) at $304000.0 in Q1 2026, $333000.0 in Q4 2025, and $342000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 40.52 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - | 285,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 285,000.00 |
| Jun 30, 2026 | 285,000.00 |
| Mar 31, 2026 | 304,000.00 |
| Mar 31, 2026 | 304,000.00 |
| Dec 31, 2025 | 333,000.00 |
| Dec 31, 2025 | 333,000.00 |
| Sep 30, 2025 | 342,000.00 |
| Sep 30, 2025 | 342,000.00 |
| Jun 30, 2025 | 340,000.00 |
| Jun 30, 2025 | 340,000.00 |
| Mar 31, 2025 | 360,000.00 |
| Mar 31, 2025 | 360,000.00 |
| Dec 31, 2024 | 508,000.00 |
| Dec 31, 2024 | 508,000.00 |
| Sep 30, 2024 | 424,000.00 |
| Sep 30, 2024 | 424,000.00 |
| Jun 30, 2024 | 336,000.00 |
| Jun 30, 2024 | 336,000.00 |
| Mar 31, 2024 | 377,000.00 |
| Mar 31, 2024 | 377,000.00 |